BE Pharma Management: what changed
Two fiscal years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
BE Pharma Management
Largest movements
- Receivables within one year +€46,041
up €46,041 (+194.4%), from €23,681 to €69,722
- Tangible fixed assets +€31,535
up €31,535 (+32.6%), from €96,616 to €128,151
of which Furniture and vehicles: +€37,369
- Reserves +€45,000
up €45,000 (+148.5%), from €30,300 to €75,300
of which Distributable reserves: +€45,000
- Debts after one year +€13,687
up €13,687 (+25.5%), from €53,765 to €67,452
- Current portion of long-term debt +€13,679
up €13,679 (+130.0%), from €10,521 to €24,200
- Other debts +€8,403
up €8,403 (+5.6%), from €149,638 to €158,041
- Gross operating margin +€23,794
up €23,794 (+37.2%), from €63,984 to €87,778
- Taxes +€5,612
up €5,612 (+55.7%), from €10,083 to €15,695
- Depreciation +€3,096
up €3,096 (+47.3%), from €6,545 to €9,641
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Cash bridge derived
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €410,020 | €492,262 | +€82,242 | +20.1% |
| Fixed assets | 21/28 | €380,084 | €411,619 | +€31,535 | +8.3% |
| Tangible fixed assets | 22/27 | €96,616 | €128,151 | +€31,535 | +32.6% |
| Land and buildings | 22 | €96,569 | €90,735 | -€5,834 | -6.0% |
| Furniture and vehicles | 24 | €47 | €37,416 | +€37,369 | +79627.4% |
| Financial fixed assets | 28 | €283,468 | €283,468 | = | 0.0% |
| Current assets | 29/58 | €29,936 | €80,642 | +€50,707 | +169.4% |
| Amounts receivable within one year | 40/41 | €23,681 | €69,722 | +€46,041 | +194.4% |
| Trade receivables | 40 | €23,681 | €69,722 | +€46,041 | +194.4% |
| Cash at bank and in hand | 54/58 | €4,866 | €6,897 | +€2,031 | +41.7% |
| Deferred charges and accrued income | 490/1 | €1,389 | €4,023 | +€2,635 | +189.7% |
| Total equity and liabilities | 10/49 | €410,020 | €492,262 | +€82,242 | +20.1% |
| Equity | 10/15 | €149,357 | €194,360 | +€45,003 | +30.1% |
| Contributions | 10/11 | €118,600 | €118,600 | = | 0.0% |
| Reserves | 13 | €30,300 | €75,300 | +€45,000 | +148.5% |
| Non-distributable reserves | 130/1 | €300 | €300 | = | 0.0% |
| Reserves not available under the articles | 1311 | €300 | €300 | = | 0.0% |
| Distributable reserves | 133 | €30,000 | €75,000 | +€45,000 | +150.0% |
| Profit (loss) carried forward | 14 | €457 | €460 | +€3 | +0.6% |
| Amounts payable | 17/49 | €260,662 | €297,901 | +€37,239 | +14.3% |
| Amounts payable after more than one year | 17 | €53,765 | €67,452 | +€13,687 | +25.5% |
| Financial debts | 170/4 | €53,765 | €67,452 | +€13,687 | +25.5% |
| Amounts payable within one year | 42/48 | €198,359 | €222,503 | +€24,145 | +12.2% |
| Current portion of amounts payable after more than one year | 42 | €10,521 | €24,200 | +€13,679 | +130.0% |
| Trade debts | 44 | €1,916 | €4,388 | +€2,472 | +129.0% |
| Suppliers | 440/4 | €1,916 | €4,388 | +€2,472 | +129.0% |
| Taxes, remuneration and social security | 45 | €36,284 | €35,874 | -€410 | -1.1% |
| Taxes | 450/3 | €7,208 | €16,979 | +€9,771 | +135.6% |
| Remuneration and social security | 454/9 | €29,075 | €18,895 | -€10,181 | -35.0% |
| Other amounts payable | 47/48 | €149,638 | €158,041 | +€8,403 | +5.6% |
| Accrued charges and deferred income | 492/3 | €8,539 | €7,946 | -€593 | -6.9% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €6,545 | €9,641 | +€3,096 | +47.3% |
| Other operating charges | 640/8 | €3,892 | €4,318 | +€426 | +11.0% |
| Gross operating margin | 9900 | €63,984 | €87,778 | +€23,794 | +37.2% |
| Operating profit (loss) | 9901 | €53,547 | €73,819 | +€20,272 | +37.9% |
| Financial charges | 65/66B | €13,787 | €13,121 | -€666 | -4.8% |
| Recurring financial charges | 65 | €13,787 | €13,121 | -€666 | -4.8% |
| Profit (loss) for the period before taxes | 9903 | €39,760 | €60,698 | +€20,937 | +52.7% |
| Income taxes | 67/77 | €10,083 | €15,695 | +€5,612 | +55.7% |
| Profit (loss) for the period | 9904 | €29,678 | €45,003 | +€15,325 | +51.6% |
| Profit (loss) for the period to be appropriated | 9905 | €29,678 | €45,003 | +€15,325 | +51.6% |
Source: filed annual accounts (NBB), fiscal years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 4 October 2026 via checked.be.